9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Presenilin-2 dampens intracellular Ca 2+ stores by increasing Ca 2+ leakage and reducing Ca 2+ uptake

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We have previously shown that familial Alzheimer’s disease mutants of presenilin-2 (PS2) and, to a lesser extent, of presenilin-1 (PS1) lower the Ca 2+ concentration of intracellular stores. We here examined the mechanism by which wild-type and mutant PS2 affect store Ca 2+ handling. By using HeLa, SH-SY5Y and MEFs as model cells, and recombinant aequorins as Ca 2+ probes, we show evidence that transient expression of either wild-type or mutant PS2 increases the passive Ca 2+ leakage: both ryanodine- and IP 3-receptors contribute to Ca 2+ exit out of the ER, whereas the ribosome translocon complex is not involved. In SH-SY5Y cells and MEFs, wild-type and mutant PS2 potently reduce the uptake of Ca 2+ inside the stores, an effect that can be counteracted by over-expression of SERCA-2B. On this line, in wild-type MEFs, lowering the endogenous level of PS2 by RNA interference, increases the Ca 2+-loading capability of intracellular stores. Furthermore, we show that in PS double knockout MEFs, reduction of Ca 2+ stores is mimicked by the expression of PS2-D366A, a loss-of-function mutant, uncleaved because also devoid of presenilinase activity but not by co-expression of the two catalytic active fragments of PS2. In summary, both physiological and increased levels of wild-type and mutant PS2 reduce the Ca 2+ uptake by intracellular stores. To exert this newly described function, PS2 needs to be in its full-length form, even if it can subsequently be cleaved.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: not found
          • Article: not found

          Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations.

            Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder. Mutations in presenilins 1 and 2 (PS1 and PS2) account for approximately 40% of familial AD (FAD) cases. FAD mutations and genetic deletions of presenilins have been associated with calcium (Ca(2+)) signaling abnormalities. We demonstrate that wild-type presenilins, but not PS1-M146V and PS2-N141I FAD mutants, can form low-conductance divalent-cation-permeable ion channels in planar lipid bilayers. In experiments with PS1/2 double knockout (DKO) mouse embryonic fibroblasts (MEFs), we find that presenilins account for approximately 80% of passive Ca(2+) leak from the endoplasmic reticulum. Deficient Ca(2+) signaling in DKO MEFs can be rescued by expression of wild-type PS1 or PS2 but not by expression of PS1-M146V or PS2-N141I mutants. The ER Ca(2+) leak function of presenilins is independent of their gamma-secretase activity. Our data suggest a Ca(2+) signaling function for presenilins and provide support for the "Ca(2+) hypothesis of AD."
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

              Mutations in presenilins (PS) are the major cause of familial Alzheimer's disease (FAD) and have been associated with calcium (Ca2+) signaling abnormalities. Here, we demonstrate that FAD mutant PS1 (M146L)and PS2 (N141I) interact with the inositol 1,4,5-trisphosphate receptor (InsP3R) Ca2+ release channel and exert profound stimulatory effects on its gating activity in response to saturating and suboptimal levels of InsP3. These interactions result in exaggerated cellular Ca2+ signaling in response to agonist stimulation as well as enhanced low-level Ca2+signaling in unstimulated cells. Parallel studies in InsP3R-expressing and -deficient cells revealed that enhanced Ca2+ release from the endoplasmic reticulum as a result of the specific interaction of PS1-M146L with the InsP3R stimulates amyloid beta processing,an important feature of AD pathology. These observations provide molecular insights into the "Ca2+ dysregulation" hypothesis of AD pathogenesis and suggest novel targets for therapeutic intervention.
                Bookmark

                Author and article information

                Journal
                J Cell Mol Med
                J. Cell. Mol. Med
                jcmm
                Journal of Cellular and Molecular Medicine
                John Wiley & Sons, Ltd (Chichester, UK )
                1582-1838
                1582-4934
                September 2009
                27 March 2009
                : 13
                : 9b
                : 3358-3369
                Affiliations
                Department of Biomedical Sciences, University of Padova Padova, Italy
                Author notes
                * Correspondence to: Cristina FASOLATO, Department of Biomedical Sciences, Via G. Colombo 3, 35121 Padova, Italy. Tel.: +39-049-827.6065 Fax: +39-049-827.6049 E-mail: cristina.fasolato@ 123456unipd.it
                * Paola PIZZO, Department of Biomedical Sciences, Via G. Colombo 3, 35121 Padova, Italy Tel: +39-049-827.6065 Fax: +39-049-827.6049 E-mail: paola.pizzo@ 123456unipd.it
                [†]

                These authors contributed equally to this work.

                Article
                10.1111/j.1582-4934.2009.00755.x
                4516491
                19382908
                ecc26a4e-9a89-4e36-b7ef-fd02286b9b7c
                © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
                History
                : 23 December 2008
                : 10 March 2009
                Categories
                Articles

                Molecular medicine
                presenilin,calcium stores,alzheimer’s disease,serca,aequorin
                Molecular medicine
                presenilin, calcium stores, alzheimer’s disease, serca, aequorin

                Comments

                Comment on this article